Skip to main content
Clinical Trials/NCT05785182
NCT05785182RecruitingNot Applicable

Optical Coherence Tomography Imaging to Visualize Bacteria or Biofilm on Hardware, Bone and Soft Tissue in Open Fracture and Infected Fracture

Dartmouth-Hitchcock Medical Center1 site in 1 country40 target enrollmentStarted: March 27, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
40
Locations
1
Primary Endpoint
Feasibility and acceptability of OCT imaging

Study Overview

Brief Summary

This is a pilot prospective, observational study of patients with open or infected fracture evaluating the feasibility and acceptability of OCT, a light-based imaging modality that requires no drug or contrast agent.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 years or older
  • Open fracture
  • Fracture Related Infection

Exclusion Criteria

  • Metatarsal fractures

Outcomes

Primary Outcomes

Feasibility and acceptability of OCT imaging

Time Frame: 36 months

The primary objective of this work is to demonstrate feasibility, acceptability, and preliminary effectiveness of Optical Coherence Tomography (OCT) to image bacteria and biofilm. Data will be analyzed accordingly: The association between optical imaging parameters (particularly around biofilm and bacterial contamination) and (1) surgical wound severity and (2) development of infection or treatment failure for infection.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ida Leah Gitajn

Section Chief, Orthopaedics

Dartmouth-Hitchcock Medical Center

Study Sites (1)

Loading locations...

Similar Trials

OCT in Open Fracture and Infected Fracture | Clinical Trial